Document is current
Any future updates will be listed below
-
Authors
Kui, Ling
Wang, Guoyun
Zhang, Li
Liao, Qifeng
Li, Xi
Wang, Shuangshuang
Chen, Tao
Leng, Bingfeng
Huang, Jinqun
Jiao, Yinming
Ye, Qiaoyuan
Zeng, Qingqian
Xiong, Kexu
-
Funding
Funding for this research was provided by:
General Program of Shenzhen Natural Science Foundation
Major Science and Technology Project of the 2023 Nanshan District Health and Health System
2022 Nanshan District Science and Technology Plan Project-Key Program
General Program of Medical Science and Technology Research Fund of Guangdong Province
Guangxi Elite Team of Medicinal Plant Conservation
- License Information
-
More Information
Article History
Received: 21 January 2026
Accepted: 14 May 2026
First Online: 21 May 2026
Declarations
:
: The authors declare no conflicts of interest.
: All animal experiments were approved by the Ethical Committee of Guangzhou Forevergen Medical Laboratory Animal Center (approval number IACUC-AEWC-F250602001, approval date 2025-6-2, protocol title: the effect of gentiopicroside on brain tissue repair in mice during the acute phase of middle cerebral artery occlusion). All animal experiments comply with the ARRIVE guidelines and be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments.
: Not applicable.
: No part of this paper was drafted, paraphrased, or ideated by any AI system; an AI tool was consulted solely for minor grammar and spelling corrections.
